Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Non-cash Items (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Non-cash Items for 6 consecutive years, with $64768.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-cash Items fell 88.84% to $64768.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $64768.0, a 88.84% decrease, with the full-year FY2024 number at $38734.0, down 93.32% from a year prior.
  • Non-cash Items was $64768.0 for Q3 2025 at Ensysce Biosciences, up from $51758.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $10.2 million in Q4 2021 to a low of $23922.0 in Q1 2023.
  • A 5-year average of $1.5 million and a median of $281660.0 in 2022 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: plummeted 99.56% in 2023, then surged 2324.38% in 2024.
  • Ensysce Biosciences' Non-cash Items stood at $10.2 million in 2021, then tumbled by 97.26% to $279306.0 in 2022, then surged by 107.56% to $579733.0 in 2023, then tumbled by 93.32% to $38734.0 in 2024, then skyrocketed by 67.21% to $64768.0 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Non-cash Items are $64768.0 (Q3 2025), $51758.0 (Q2 2025), and $38749.0 (Q1 2025).